Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell even higher." And for investors following this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving in that direction. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades. Eve ...

October 7, 2024 Jakarta, Indonesia and Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Siloam Hospitals Group, Indonesia's leading private healthcare provider, have signed a Memorandum of Understanding (MoU) to advance AI capabilities and development in the healthcare sector in Indonesia. The strategic collaboration, in partnership with the Universitas Pelita Harapan (UPH) Medical Sciences Group, will focus on capacity building, knowledge sharing, ...

October 3, 2024 Philips helps healthcare organizations worldwide assess and mitigate their environmental impact while enabling better care and better care outcomes for more patients at lower cost Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced significant greenhouse gas (GHG) emissions reduction results following collaboration with customers worldwide to assess and mitigate their carbon footprints, while also enhancing patient care and ...

Philips Sonicare is encouraging viewers to switch from their manual toothbrush and elevate their routine with a power toothbrush, like Philips Sonicare DiamondClean Smart, which removes up to 20X more plaque along the gumline [1] and delivers more brush strokes in two minutes than an entire month of manual brushing. This helps achieve an efficient, exceptional clean and confidence going into the big moments in daily life. McKinnon stars in a series of advertisements that make audiences confront their lacklu ...

Investors with an interest in Medical - Products stocks have likely encountered both Royal Philips (PHG) and EssilorLuxottica Unsponsored ADR (ESLOY) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The Zacks Rank favors stocks with strong earnings estimate revision tr ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor. Zacks Premium also includes the Zacks Style Scores. What are the Zacks Style Scores? Develo ...

Core Viewpoint - The article highlights Koninklijke Philips (PHG) as a strong value investment opportunity, showcasing its favorable valuation metrics compared to industry averages [4][5][6][7]. Valuation Metrics - PHG has a Zacks Rank of 2 (Buy) and an A for Value, indicating strong potential for value investors [4]. - The stock's P/E ratio is 18.09, significantly lower than the industry average of 22.20 [4]. - PHG's Forward P/E has fluctuated between 12.29 and 18.27 over the past 12 months, with a median of 14.35 [4]. - The PEG ratio for PHG is 0.94, compared to the industry's average PEG of 2.18, suggesting it is undervalued relative to its expected earnings growth [5]. - Over the past 52 weeks, PHG's PEG has ranged from 0.78 to 1.33, with a median of 0.92 [5]. - The P/B ratio for PHG is 2.26, which is attractive compared to the industry average of 5.35 [6]. - PHG's P/B has varied between 1.28 and 2.28 over the past 12 months, with a median of 1.58 [6]. Investment Outlook - The combination of these valuation metrics indicates that Koninklijke Philips is likely undervalued, making it one of the strongest value stocks in the market [7].

Core Insights - The collaboration between Royal Philips and Jackson Health System reveals significant sustainability benefits from transitioning to Philips' next-generation monitoring solutions, including a 47% reduction in carbon emissions and substantial cost savings [1][2][3] Group 1: Sustainability Impact - The Life Cycle Assessment (LCA) indicates that Philips patient monitors can reduce carbon emissions by 685.1 tons of CO2e, which is a 47% decrease compared to previous systems [1][2] - The transition eliminates the need for approximately 420,000 disposable AA batteries and 6.5 million sheets of paper, leading to an estimated savings of $1.2 million over a 10-year device lifetime [1][2] - Philips IntelliVue and EarlyVue monitors contribute to a reduction of 508 tons of CO2e across all lifecycle facets, with additional savings from battery and paper reductions amounting to 177.1 tons [2] Group 2: Operational Efficiency - The previous telemetry monitors required hundreds of disposable AA battery replacements weekly and involved manual paper processes, while Philips monitors utilize rechargeable batteries and automate workflows, reducing waste and allowing clinicians to focus more on patient care [2] - Jackson Health System has implemented sustainable procurement practices, including trading in legacy monitors for refurbishment and recycling, promoting circularity and minimizing landfill waste [3] Group 3: Industry Leadership - Jackson Health System is recognized for its commitment to sustainable practices that enhance both human and environmental health, balancing advanced technology needs with sustainability [3] - Philips North America emphasizes the importance of integrating advanced technology to reduce carbon emissions and waste, which can improve staff satisfaction and productivity while enhancing patient care [4]

Enhanced longer version of Philips LumiGuide Navigation Wire enables US clinicians to visualize a broader range of catheters Internationally recognized vascular surgeon Carlos Timaran, MD, was the first to use the new LumiGuide wire to perform a complex aortic repair, Procedure marks the world's 1000th procedure assisted by Philips' unique Fiber Optic RealShape (FORS) guidance technology Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced ...

Core Viewpoint - Investors in the Medical - Products sector should consider Royal Philips (PHG) and EssilorLuxottica Unsponsored ADR (ESLOY) for potential value opportunities, with PHG currently showing stronger value metrics [1]. Group 1: Zacks Rank and Earnings Outlook - Royal Philips has a Zacks Rank of 2 (Buy), indicating a favorable earnings outlook, while EssilorLuxottica has a Zacks Rank of 4 (Sell), suggesting a weaker earnings outlook [3]. - The improvement in earnings outlook for PHG is stronger compared to ESLOY, making it a more attractive option for value investors [3]. Group 2: Valuation Metrics - PHG has a forward P/E ratio of 20.10, significantly lower than ESLOY's forward P/E of 31.46, indicating that PHG may be undervalued relative to ESLOY [5]. - The PEG ratio for PHG is 1.04, while ESLOY's PEG ratio is 3.49, further suggesting that PHG offers better value considering expected earnings growth [5]. - PHG's P/B ratio stands at 2.21, compared to ESLOY's P/B of 2.49, reinforcing the notion that PHG is a more favorable investment based on valuation metrics [6]. Group 3: Overall Value Grades - PHG has a Value grade of A, while ESLOY has a Value grade of D, indicating that PHG is perceived as a superior value option based on various financial metrics [6].